Expert Group advises States not to chart separate pathways of procurement of vaccines
National

Expert Group advises States not to chart separate pathways of procurement of vaccines

NetIndian News Network

New Delhi, August 13, 2020

The National Expert Group on Vaccine Administration for COVID-19, which met here for the first time yesterday, has advised all States not to chart separate pathways of procurement of vaccines.

The meeting was chaired by Dr V K Paul, Member, Niti Aayog, along with the Secretary, Ministry of Health and Family Welfare, as co-Chair.

An official press release said the meeting deliberated on conceptualization and implementation mechanisms for creation of a digital infrastructure for inventory management and delivery mechanism of the vaccine including tracking of vaccination process with particular focus on last mile delivery.

They discussed the broad parameters guiding the selection of COVID-19 vaccine candidates for the country and sought inputs from Standing Technical Sub-Committee of National Technical Advisory Group on Immunization (NTAGI).

The group considered procurement mechanisms for COVID-19 vaccine, including both indigenous and international manufacturing along with guiding principles for prioritization of population groups for vaccination.

The expert group discussed the financial resources required for procurement of COVID-19 vaccine and various options of financing the same. Available options in terms of delivery platforms, cold chain and associated infrastructure for roll out of COVID-19 vaccination were also taken up. Further, strategy and follow-up action on all possible scenarios to ensure equitable and transparent delivery of vaccine was deliberated upon. Issues related to vaccine safety and surveillance were taken up and strategy for community involvement through transparent information and awareness creation were discussed.

India’s support to its key neighbors and development partner countries for COVID-19 vaccines was deliberated upon.

The expert group discussed that India will leverage domestic vaccine manufacturing capacity and will also engage with all international players for early delivery of vaccines not only in India but also in low- and middle-income countries.

NNN

NetIndian
www.netindian.in